|
|||||
|
|
Six‐year multi‐centre,observational, post‐marketing surveillance of the safety of the HPV‐16/18 AS04‐adjuvanted vaccine in women aged 10–25 years in Korea |
|
| Authors: | Chul‐Jung Kim Rok Song Jing Chen Fernanda Tavares Da Silva Kusuma B. Gopala Joon Hyung Kim Dan Bi Jong Sup Park |
| Affiliation: | 1. Department of Obstetrics and Gynecology, College of Medicine, Konyang University, Daejeon, Korea;2. GSK Vaccines, Seoul, Korea;3. GSK Pte Ltd, Singapore, Singapore;4. GSK Vaccines, Wavre, Belgium;5. GSK Pharmaceuticals Ltd, Bangalore, India;6. Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea |
| Abstract: | |
| Keywords: | Korea post‐marketing surveillance safety HPV‐16/18 AS04‐adjuvanted vaccine |